基于解释结构模型的儿童用药有效供给制约因素分析  

Restraining Factors for the Effective Supply of Drug for Children Based on Interpretative Structural Modeling

作　　者：卫陈[1,2] 顾海[1] 

机构地区：[1]南京大学政府管理学院公共卫生管理与医疗保障政策研究中心,江苏省南京市210093 [2]南京中医药大学经贸管理学院

出　　处：《中国全科医学》2015年第31期3872-3875,共4页Chinese General Practice

基　　金：江苏省教育厅高校哲学社会科学基金指导项目(2013SJD630047)--我国儿童用药有效供给模式及其政策体系构建研究;国家自然科学基金资助项目(71373120)--统筹城乡医保制度对居民健康及医疗利用影响研究

摘　　要：本文从儿童用药供给的现状出发,通过文献研究和专家访谈分析儿童用药有效供给的制约因素,应用解释结构模型分析制约因素间的结构层次关系。结果表明,制约儿童用药有效供给不足的因素共有9个,其中企业没有合理利润是最直接原因,研发成本高、临床试验基础薄弱、市场不稳定、医保无政策倾斜以及用药不规范是中间层因素,相关法律法规缺失、招标采购政策壁垒以及临床试验受试者缺乏是问题的根源。From the perspective of current status of drug supply for children, the article analyzed the restraining factors for the effective drug supply for children by literature view and expert interview and analyzed the structural and hierarchical relation among restraining factors by interpretative structural modeling. We found 9 factors for the inefficient drug supply for children, among which the most direct reason is the lack of rational profit of companies ; high research cost, weak foundation of clinical trial, unstable market, the absence of preferential policy of medical insurance and nonstandard drug administration are intermediary factors ; the lack of relevant laws and regulations, barriers of purchasing by invitation to bid and the lack of subjects for clinical trials are the root causes of the problem.

关 键 词：儿童 用药 有效供给 制约因素 解释结构模型 

分 类 号：R595.485[医药卫生—内科学]